Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Index- P/E- EPS (ttm)-0.33 Insider Own88.82% Shs Outstand13.01M Perf Week-0.82%
Market Cap78.72M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float1.46M Perf Month-25.49%
Income-4.30M PEG- EPS next Q- Inst Own0.14% Short Float1.59% Perf Quarter-16.05%
Sales0.00M P/S- EPS this Y- Inst Trans186.64% Short Ratio0.21 Perf Half Y16.17%
Book/sh0.63 P/B9.58 EPS next Y- ROA-40.85% Short Interest0.02M Perf Year-63.33%
Cash/sh0.61 P/C9.89 EPS next 5Y- ROE-42.49% 52W Range3.03 - 32.44 Perf YTD-42.38%
Dividend Est.- P/FCF- EPS past 5Y-60.65% ROI-52.18% 52W High-81.35% Beta-0.64
Dividend TTM- Quick Ratio41.92 Sales past 5Y0.00% Gross Margin- 52W Low99.67% ATR (14)0.82
Dividend Ex-DateFeb 15, 2018 Current Ratio41.92 EPS Y/Y TTM26.73% Oper. Margin- RSI (14)48.63 Volatility8.73% 13.01%
Employees12 Debt/Eq0.01 Sales Y/Y TTM- Profit Margin- Recom- Target Price-
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q15.45% Payout- Rel Volume0.22 Prev Close5.82
Sales Surprise- EPS Surprise- Sales Q/Q- Earnings- Avg Volume110.53K Price6.05
SMA20-3.06% SMA502.41% SMA200-3.76% Trades Volume1,304 Change3.95%
Jul-23-24 04:02PM
Nov-15-23 04:31PM
Jul-31-23 08:15AM
Apr-03-23 07:25AM
Feb-21-23 06:36AM
06:49AM Loading…
Nov-21-22 06:49AM
Nov-15-22 07:55AM
Oct-25-22 06:55AM
Sep-14-22 06:55AM
Sep-12-22 09:15AM
Jun-20-22 05:27AM
May-24-22 05:46AM
May-18-22 08:05AM
06:14AM
May-16-22 08:56AM
10:03AM Loading…
Apr-14-22 10:03AM
Apr-07-22 06:09AM
Mar-01-22 08:30AM
Feb-17-22 11:40AM
Feb-16-22 08:42PM
Dec-13-21 08:35AM
Nov-22-21 08:15AM
08:00AM
Nov-02-21 04:00AM
Oct-19-21 11:44AM
Sep-10-21 06:18AM
02:42AM
Sep-02-21 08:00AM
Aug-20-21 08:00AM
Aug-05-21 08:00AM
04:05PM Loading…
Jul-20-21 04:05PM
Jul-16-21 11:43AM
Regencell Bioscience Holdings Ltd. engages in the research, development, and commercialization of traditional Chinese medicine. It seeks the treatment of neurocognitive disorders and degeneration, specifically attention deficit hyperactivity disorder and autism spectrum disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.